Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study.

MLA

Herrett, Emily, et al. “Eligibility and Subsequent Burden of Cardiovascular Disease of Four Strategies for Blood Pressure-Lowering Treatment: A Retrospective Cohort Study.” Lancet (London, England), vol. 394, no. 10199, Aug. 2019, pp. 663–71. EBSCOhost, https://doi.org/10.1016/S0140-6736(19)31359-5.

APA

Herrett, E., Gadd, S., Jackson, R., Bhaskaran, K., Williamson, E., van Staa, T., Sofat, R., Timmis, A., & Smeeth, L. (2019). Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study. Lancet (London, England), 394(10199), 663–671. https://doi.org/10.1016/S0140-6736(19)31359-5

Chicago

Herrett, Emily, Sarah Gadd, Rod Jackson, Krishnan Bhaskaran, Elizabeth Williamson, Tjeerd van Staa, Reecha Sofat, Adam Timmis, and Liam Smeeth. 2019. “Eligibility and Subsequent Burden of Cardiovascular Disease of Four Strategies for Blood Pressure-Lowering Treatment: A Retrospective Cohort Study.” Lancet (London, England) 394 (10199): 663–71. doi:10.1016/S0140-6736(19)31359-5.